ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,230.54
      -1.04%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Bioenvision (MM) (BIVN)

      7. Bioenvision (MM) (BIVN) News

      BIVN

      Bioenvision (BIVN)

      Bioenvision (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BIVN
      DateTimeSourceHeadlineSymbolCompany
      04/11/20178:30AMGlobeNewswire Inc.MonoSol Rx Appoints James S. Scibetta to Board of DirectorsNASDAQ:BIVNBioenvision (MM)
      10/23/20075:40PMPR Newswire (US)HealthShares(TM) Announces Change to the HealthShares(TM) Emerging Cancer IndexNASDAQ:BIVNBioenvision (MM)
      10/22/20074:50PMPR Newswire (US)Bioenvision Shareholders Approve Acquisition by Genzyme CorporationNASDAQ:BIVNBioenvision (MM)
      10/10/20072:57PMPR Newswire (US)Delaware Court Approves Bioenvision, Genzyme Joint PetitionNASDAQ:BIVNBioenvision (MM)
      10/05/20075:00PMEdgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
      10/05/20075:00PMEdgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
      10/05/20078:34AMEdgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
      10/05/20078:34AMEdgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
      10/04/20075:14PMEdgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
      10/04/20075:14PMEdgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
      10/01/20079:17AMEdgar (US Regulatory)Bioenvision Inc (Other) (SC 13D/A)NASDAQ:BIVNBioenvision (MM)
      09/27/20078:45AMPR Newswire (US)Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding ShareNASDAQ:BIVNBioenvision (MM)
      09/27/20078:31AMEdgar (US Regulatory)Bioenvision Inc (Other) (DFAN14A)NASDAQ:BIVNBioenvision (MM)
      09/27/20078:30AMEdgar (US Regulatory)Bioenvision Inc (Other) (SC 13D/A)NASDAQ:BIVNBioenvision (MM)
      09/20/20072:15PMEdgar (US Regulatory)Bioenvision Inc (Other) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
      09/19/20075:11PMEdgar (US Regulatory)Bioenvision Inc (Other)NASDAQ:BIVNBioenvision (MM)
      09/06/20079:49AMPR Newswire (US)Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues CompanyNASDAQ:BIVNBioenvision (MM)
      08/16/20078:00AMBusiness WireBioenvision Provides Evoltra(R) (clofarabine) Regulatory UpdateNASDAQ:BIVNBioenvision (MM)
      07/27/20076:24PMPR Newswire (US)Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
      07/26/20074:30PMBusiness WireBioenvision, Inc. Says Securities Class Action Litigation Without MeritNASDAQ:BIVNBioenvision (MM)
      07/16/20079:00AMBusiness WireDr. Andrew N. Schiff and Steven A. Elms Resign from Bioenvision Board of DirectorsNASDAQ:BIVNBioenvision (MM)
      07/10/20072:44PMPR Newswire (US)/C O R R E C T I O N -- Genzyme Corporation/NASDAQ:BIVN
      07/10/20079:27AMPR Newswire (US)Genzyme Completes Tender Offer to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
      07/02/200710:45AMPR Newswire (US)Genzyme Extends Tender Offer to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
      06/27/20071:30PMPR Newswire (US)Genzyme Corporation Moves Closer to Acquiring Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
      05/29/200710:09AMPR Newswire (US)Genzyme Corporation to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
      05/08/20077:00AMBusiness WireBioenvision Reports Third Quarter 2007 Financial ResultsNASDAQ:BIVNBioenvision (MM)
      05/07/20077:02AMBusiness WireBioenvision Receives $7.4 Million in Warrant Exercises by Perseus-Soros Biopharmaceutical Fund & SCO CapitalNASDAQ:BIVNBioenvision (MM)
      05/03/20077:02AMBusiness WireBioenvision to Present at 2007 UBS Global Generic and Specialty Pharmaceuticals ConferenceNASDAQ:BIVNBioenvision (MM)
      05/01/20077:02AMBusiness WireBioenvision to Hold Fiscal 2007 Third Quarter Financial Results Conference Call on Tuesday, May 8, 2007NASDAQ:BIVNBioenvision (MM)
       Showing the most relevant articles for your search:NASDAQ:BIVN